PTPRC and head and neck squamous cell carcinoma: In this preliminary study, we used a slightly modified methodology including density gradient centrifugation but no depletion of CD45-positive cells and addressed the question whether different types of CTC are identifiable in the peripheral blood of patients with HNSCC and, if so, whether their distribution may serve as a predictor of treatment response or outcome.